By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


SEARCH JOBS



Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website – www.regeneron.com
Check out our openings – http://careers.regeneron.com


Key Statistics


Email:
Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN
 





Collaborations

Sanofi US 

Bayer 

Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 





Company News
Regeneron (REGN)'s Top Execs Get a Huge Pay Cut in 2016 But It's Still More Than Most of Us Have Ever Dreamed of 4/26/2017 5:31:01 AM
Sanofi (SNY) And Regeneron (REGN) Announce FDA Approval Of A New Once-Monthly Dosing Option For Praluent (Alirocumab) Injection 4/25/2017 6:25:58 AM
Sanofi (SNY) And Regeneron (REGN) Receive CHMP Positive Opinion For Kevzara (Sarilumab) To Treat Adult Patients With Moderately To Severely Active Rheumatoid Arthritis 4/24/2017 11:49:49 AM
Regeneron (REGN) And Sanofi (SNY) Receive Positive CHMP Opinion For Kevzara (Sarilumab) To Treat Adult Patients With Moderately To Severely Active Rheumatoid Arthritis 4/24/2017 7:45:13 AM
Regeneron (REGN) To Report First Quarter 2017 Financial And Operating Results And Host Conference Call And Webcast On May 4, 2017 4/14/2017 11:53:32 AM
FDA Calls Regeneron (REGN)'s Evinacumab a Breakthrough 4/6/2017 6:32:23 AM
Sarepta (SRPT) CEO Gives CMO Role to Former Amgen (AMGN)-Regeneron (REGN) Alum 4/4/2017 5:55:39 AM
This Game-Changing Drug Could Be Regeneron (REGN)'s Next Blockbuster 3/30/2017 6:44:22 AM
Regeneron (REGN)'s New Drug Price Could Disappoint Everyone. Here's Why That's A Good Thing 3/29/2017 6:01:41 AM
Sanofi (SNY) And Regeneron (REGN) Announce FDA Approval Of Dupixent (Dupilumab), The First Targeted Biologic Therapy For Adults With Moderate-To-Severe Atopic Dermatitis 3/28/2017 10:01:59 AM
12345678910...
//-->